Alana Brennan
Profiles

Alana T Brennan, PhD

Associate Professor , Global Health - Boston University School of Public Health

617-358-2407
abrennan@bu.edu
Crosstown Center
View Full Profile at BUMC

Biography

Alana Brennan, PhD, MPH is an Associate Professor in the Department of Global Health at the Boston University School of Public Health. She received both her MPH in Epidemiology and PhD in Epidemiology from the Boston University School of Public Health. Her areas of expertise are in HIV, tuberculosis, non-communicable chronic disease, and health systems research.

Other Positions

  • Associate Professor, Epidemiology - Boston University School of Public Health

Education

  • Boston University School of Public Health, PhD Field of Study: Epidemiology
  • Boston University School of Public Health, MPH Field of Study: Epidemiology
  • Knox College, BS Field of Study: Biology

Websites

Classes Taught

  • SPHEP755

Publications

  • Published on 4/30/2026

    Zheng A, Murray EJ, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Pisa PT, Fox MP, Maskew M. One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. Open Forum Infect Dis. 2026 May; 13(5):ofag151. PMID: 42078192.

     Read At: PubMed
  • Published on 3/27/2026

    Kileel EM, Malvestutto CD, Zanni MV, Davies-Smith E, Fichtenbaum CJ, Lake JE, Lo J, Aberg JA, Martinez E, Patel K, Bloomfield GS, Chu SM, Awwad A, Diggs MR, Lu AB, Bares SH, Berrner D, Smieja M, Okeke NL, Kumar P, João E, Currier JS, Lu MT, Fox MP, Brennan AT, Douglas PS, Grinspoon SK, Ribaudo HJ. Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE. Lancet HIV. 2026 May; 13(5):e306-e315. PMID: 41911941.

     Read At: PubMed
  • Published on 3/18/2026

    Pederson AM, Buto P, Zimmerman SC, Velez M, Sims KD, Murchland AR, Wang J, Brennan AT, Glymour MM, Weuve J. Type 1 Diabetes and Incident Dementia: An Analysis in the All of Us Cohort. Neurology. 2026 Apr 14; 106(7):e214805. PMID: 41849727.

     Read At: PubMed
  • Published on 3/10/2026

    Zheng A, Fox MP, Greener R, Kileel EM, Bor J, Venter WD, Pisa PT, Murray EJ, Brennan AT, Maskew M. Initiation of dolutegravir vs efavirenz on 12- and 24-month weight, body mass index, blood pressure, and incident hypertension: A target trial emulation. Ann Epidemiol. 2026 May; 117:110074. PMID: 41819297.

     Read At: PubMed
  • Published on 2/23/2026

    Kalbus A, Tanasache OA, Law C, Adams J, Breeze P, Brennan A, Brown KA, Cummins S, Marks D, O'Neill S, Smith R, Cornelsen L. How did labelling provision on menus for online food delivery change after implementation of England's calorie labelling regulations? Health Place. 2026 Mar; 98:103635. PMID: 41734677.

     Read At: PubMed
  • Published on 12/24/2025

    Kuhn L, Brennan AT. No cause for complacency regarding health of children who are HIV-exposed but uninfected. AIDS. 2026 Feb 01; 40(2):249-251. PMID: 41457985.

     Read At: PubMed
  • Published on 12/10/2025

    Sass N, Havrylenko H, Gerber F, Amstutz A, Rosen S, Brennan A, Maskew M, Koenig S, Dorvil N, Geng EH, Glass T, Ford NP, Labhardt ND, Schandelmaier S. Effect of same-day HIV treatment initiation (SDI) on 1-year outcomes in low- and middle-income countries: systematic review and meta-analysis of randomised trials. BMJ Glob Health. 2025 Dec 10; 10(12). PMID: 41371927.

     Read At: PubMed
  • Published on 12/1/2025

    Dzomba A, Shumba K, Nattey C, Lauren E, Brennan AT, McLoed W, Fox MP, Bor J, Onoya D. HIV Patient Treatment Adherence Trajectories in First 24 months After ART Initiation Among Adults: An Electronic Health Records Cohort From South Africa. J Acquir Immune Defic Syndr. 2025 Dec 01; 100(4):305-314. PMID: 40778758.

     Read At: PubMed
  • Published on 10/21/2025

    Brennan AT, Lauren E, Bor J, George JA, Khoza S, Mlisana K, Kileel EM, Rosen S, Raal F, Hibberd P, Fox MP, Crowther NJ. Gaps in the Type 1 Diabetes Mellitus care cascade: a national perspective using South Africa's National Health Laboratory Service (NHLS) database. medRxiv. 2025 Oct 21. PMID: 41040711.

     Read At: PubMed
  • Published on 9/22/2025

    Zheng A, Brennan AT, Greener R, Kileel EM, Bor J, Venter WDF, Murray EJ, Pisa PT, Goeieman B, Fox MP, Maskew M. Initiation of dolutegravir vs. efavirenz on 12- and 24-month retention and viral suppression: a target trial emulation. Infect Dis (Lond). 2026 Feb; 58(2):198-208. PMID: 40982349.

     Read At: PubMed

View 90 more publications:View Full Profile at BUMC

News & In the Media

View all profiles